In conclusion, our study shows that mitotic kinesins are potential therapeutic vulnerabilities for MPNSTs and demonstrates that the combined suppression of KIF11 and KIF15 together with BRD4 inhibition exhibit in vitro synergistic antitumoral effects in MPNST cells. Here, KIF11 is linked to malignant peripheral nerve sheath tumor.